Zacks: Analysts Expect IMAX Co. (NYSE:IMAX) Will Post Quarterly Sales of $57.97 Million

Equities research analysts expect IMAX Co. (NYSE:IMAXGet Rating) to post $57.97 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for IMAX’s earnings, with the highest sales estimate coming in at $59.44 million and the lowest estimate coming in at $57.10 million. IMAX posted sales of $38.75 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 49.6%. The business is expected to report its next quarterly earnings report after the market closes on Monday, January 1st.

On average, analysts expect that IMAX will report full-year sales of $338.42 million for the current year, with estimates ranging from $319.10 million to $349.72 million. For the next fiscal year, analysts expect that the firm will post sales of $378.53 million, with estimates ranging from $359.10 million to $391.88 million. Zacks Investment Research’s sales calculations are an average based on a survey of analysts that follow IMAX.

IMAX (NYSE:IMAXGet Rating) last posted its quarterly earnings results on Wednesday, February 23rd. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.06 by $0.15. The company had revenue of $108.57 million for the quarter, compared to the consensus estimate of $87.16 million. IMAX had a negative return on equity of 7.10% and a negative net margin of 8.76%.

A number of brokerages recently issued reports on IMAX. Benchmark reiterated a “buy” rating and issued a $28.00 price target on shares of IMAX in a research note on Thursday, February 24th. started coverage on shares of IMAX in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the stock. According to, the company presently has an average rating of “Buy” and a consensus target price of $24.86.

NYSE IMAX opened at $16.84 on Monday. IMAX has a 12 month low of $13.60 and a 12 month high of $23.57. The stock’s fifty day moving average price is $18.81 and its 200-day moving average price is $18.81. The stock has a market cap of $986.40 million, a P/E ratio of -44.32, a P/E/G ratio of 3.81 and a beta of 1.46.

In other news, EVP Jacqueline Bassani sold 6,000 shares of the stock in a transaction on Wednesday, March 16th. The stock was sold at an average price of $18.13, for a total transaction of $108,780.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 23.20% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Point72 Hong Kong Ltd purchased a new position in shares of IMAX during the 4th quarter worth $29,000. National Bank of Canada FI purchased a new position in IMAX during the fourth quarter valued at $46,000. Victory Capital Management Inc. bought a new stake in IMAX during the third quarter valued at about $179,000. Bridgefront Capital LLC purchased a new stake in IMAX in the fourth quarter worth about $180,000. Finally, Probity Advisors Inc. bought a new position in shares of IMAX in the fourth quarter worth about $193,000. 90.28% of the stock is owned by hedge funds and other institutional investors.

IMAX Company Profile (Get Rating)

IMAX Corporation, together with its subsidiaries, operates as an entertainment technology company worldwide. It offers cinematic solution through proprietary software, theater architecture, intellectual property, and specialized equipment. The company offers IMAX Digital Re-Mastering (DMR), a proprietary technology that digitally enhances the image resolution, visual clarity, and sound quality of motion picture films for projection on IMAX screens; IMAX theater systems to exhibitor customers through sales, leases, and joint revenue sharing arrangements; and digital projection systems.

Read More

Get a free copy of the Zacks research report on IMAX (IMAX)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for IMAX (NYSE:IMAX)

Receive News & Ratings for IMAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAX and related companies with's FREE daily email newsletter.